[
  {
    "ts": null,
    "headline": "Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics",
    "summary": "A look at Exact Sciences Corporationâs acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening outlook. Click for this EXAS update.",
    "url": "https://finnhub.io/api/news?id=f77dc3763c02d19772c63120055e6d2dd8dd7b11f203fec18241777894fdfa6b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767805874,
      "headline": "Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics",
      "id": 138030059,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2188060332/image_2188060332.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "A look at Exact Sciences Corporationâs acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening outlook. Click for this EXAS update.",
      "url": "https://finnhub.io/api/news?id=f77dc3763c02d19772c63120055e6d2dd8dd7b11f203fec18241777894fdfa6b"
    }
  },
  {
    "ts": null,
    "headline": "PBH or ABT: Which Is the Better Value Stock Right Now?",
    "summary": "PBH vs. ABT: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=9b2587f873e51d6f6afe1c56d2991c092f1fff30387b920169f2db18500e6038",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767804006,
      "headline": "PBH or ABT: Which Is the Better Value Stock Right Now?",
      "id": 138033250,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "PBH vs. ABT: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=9b2587f873e51d6f6afe1c56d2991c092f1fff30387b920169f2db18500e6038"
    }
  },
  {
    "ts": null,
    "headline": "Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada",
    "summary": "Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in every province across Canadavi, in federal plans like Non-Insured Health Benefits (NIHB)vi and by a majority of employer-sponsored workplace benefits programs.i Coverage means more Canadians living with diabetes can experience the ease of the world's smallest glucose sensor.iv,v",
    "url": "https://finnhub.io/api/news?id=c8560da5b5d93f0a1e484121a3d395c586403be5dd4b8e426be39e0d90a2274d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767794400,
      "headline": "Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada",
      "id": 138027187,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in every province across Canadavi, in federal plans like Non-Insured Health Benefits (NIHB)vi and by a majority of employer-sponsored workplace benefits programs.i Coverage means more Canadians living with diabetes can experience the ease of the world's smallest glucose sensor.iv,v",
      "url": "https://finnhub.io/api/news?id=c8560da5b5d93f0a1e484121a3d395c586403be5dd4b8e426be39e0d90a2274d"
    }
  },
  {
    "ts": null,
    "headline": "Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy",
    "summary": "The two properties strengthen the Company's presence in Illinois, where it currently owns and manages three other properties. LAS VEGAS, NEVADA / ACCESS Newswire / January 7, 2026 / Sentinel Net Lease (the \"Company\") announced today that Sentinel ...",
    "url": "https://finnhub.io/api/news?id=ec9e23f18251fce5e7490b51b336dfa99157d8e26789e692e2651298e6583df4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767790800,
      "headline": "Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy",
      "id": 138027188,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The two properties strengthen the Company's presence in Illinois, where it currently owns and manages three other properties. LAS VEGAS, NEVADA / ACCESS Newswire / January 7, 2026 / Sentinel Net Lease (the \"Company\") announced today that Sentinel ...",
      "url": "https://finnhub.io/api/news?id=ec9e23f18251fce5e7490b51b336dfa99157d8e26789e692e2651298e6583df4"
    }
  },
  {
    "ts": null,
    "headline": "Abbott: Not Cheap, But Built To Compound In Uncertain Markets",
    "summary": "Buy Abbott: defensive compounder with recurring cash flow. Libre diabetes devices drive growth; 2025 guidance reaffirmed. Know more about ABT stock here.",
    "url": "https://finnhub.io/api/news?id=5147beef7b65e0651121fae3b0a1dea7986b2b5c38a3f643f42bca3b92785dc6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767777476,
      "headline": "Abbott: Not Cheap, But Built To Compound In Uncertain Markets",
      "id": 138026572,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2155841301/image_2155841301.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Buy Abbott: defensive compounder with recurring cash flow. Libre diabetes devices drive growth; 2025 guidance reaffirmed. Know more about ABT stock here.",
      "url": "https://finnhub.io/api/news?id=5147beef7b65e0651121fae3b0a1dea7986b2b5c38a3f643f42bca3b92785dc6"
    }
  },
  {
    "ts": null,
    "headline": "3 Healthcare Stocks with Exciting Potential",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 19.9% gain over the past six months, beating the S&P 500 by 9.1 percentage points.",
    "url": "https://finnhub.io/api/news?id=dded7f204c2816900de3c24c52b81f1fd7ff96d1571f6fcd2217757bbc0328b9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767760564,
      "headline": "3 Healthcare Stocks with Exciting Potential",
      "id": 138025818,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 19.9% gain over the past six months, beating the S&P 500 by 9.1 percentage points.",
      "url": "https://finnhub.io/api/news?id=dded7f204c2816900de3c24c52b81f1fd7ff96d1571f6fcd2217757bbc0328b9"
    }
  }
]